El Fondo mundial de lucha contra el SIDA, la tuberculosis y la malaria

Esta información está disponible en inglés solamente

Funding Decisions

Transitional Funding Mechanism
Round Based Channel: 10 | 9 | 8 | 7 | 6 | 5 | 4 | 3 | 2 | 1
Rolling Continuation Channel (RCC): Final | 8 | 7 | 6 | 5 | 4 | 3 | 2 | 1
Affordable Medicines Facility - malaria (AMFm) phases: 1

Transitional Funding Mechanism - August 2012
Total*	45 disease proposals approved in 37 different countries, totaling a maximum upper-ceiling of US$ 419.8 million (categories 1-3). 11 proposals from 10 countries must be revised and resubmitted for a second TRP review before a funding recommendation can be made (category 4), for a potential total two-year upper ceiling of US$ 91.2 million.
By Disease (Cat. 1-3)	HIV US$ 111.7 million in 16 countries Tuberculosis US$ 103.8 million in 18 countries Malaria US$ 204.2 million in 11 countries
Documentation	TRP Report (PDF - 1105 KB) Approved Proposals Proposals Not Approved Board Decision Point on TFM
	Please note: So as not to distort the country statistics, 1 multi-country proposal has been counted as 1 country count, unless otherwise stated. * US dollar/Euro exchange rate, 1 July 2012. Please note that amounts per region and disease do not take into account any anticipated adjustments to be achieved during TRP clarifications and grant negotiations.

Round 10 - December 2010
Total	79 disease proposals (including HSS requests) approved in 64 different countries, totaling a maximum upper-ceiling of US$ 1.73 billion.
By Global Fund Region (initial two years)	East Asia & the Pacific - US$ 211 million for 14 disease proposals (including HSS requests) in 11 countries Eastern Europe & Central Asia - US$ 208 million for 10 disease proposals in 8 countries Latin America & the Caribbean - US$ 36 million for 8 disease proposals (including HSS requests) in 8 countries North Africa & the Middle East - US$ 261 million for 14 disease proposals (including HSS requests) in 9 countries South West Asia - US$ 82 million for 5 disease proposals (including HSS requests) in 5 countries Sub-Saharan Africa: East Africa - US$ 330 million for 9 disease proposals (including HSS requests) in 5 countries Sub-Saharan Africa: Southern Africa - US$ 336 million for 7 disease proposals in 6 countries Sub-Saharan Africa: West & Central Africa - 269 million for 12 disease proposals (including HSS requests) in 9 countries
By Disease (initial two years, excluding HSS requests)	HIV US$ 732 million in 32 countries Tuberculosis US$ 300 million in 26 countries Malaria US$ 574 million in 18 countries
Documentation	TRP Report (PDF - 1012 KB) Proposals Not Approved Board Decision Point on Round 10 (GF/B22/DP 27) download (PDF - 310 KB) Detailed information on Round 10 is also available on The Global Fund Observer, an independent newsletter about the Global Fund provided by Aidspan: http://www.aidspan.org/documents/gfo/GFO-Issue-135.doc
	Please note: So as not to distort the country statistics, 1 multi-country proposal has been counted as 1 country count, unless otherwise stated * US dollar/Euro exchange rate, 1 December 2010. Please note that amounts per region and disease do not take into account any anticipated adjustments to be achieved during TRP clarifications and grant negotiations.

Round 9 and NSA - November 2009*
Total	90 Round 9 disease proposals (including HSS requests) and National Strategy Applications (NSA) in 69 different countries approved, in principle, by the Board on 10 November 2009. It is noted that the TRP funding recommendations are collectively intended to be subject to a 10% adjustment downwards for efficiency, resulting in an adjusted maximum Phase 1 upper-ceiling funding of US$ 2.38 billion.
By Region	East Asia & the Pacific - US$ 473.6** million for 12 disease proposals (including HSS requests) in 7 countries Eastern Europe & Central Asia - US$ 107.6** million for 12 disease proposals in 10 countries Latin America & the Caribbean - US$ 185.5** million for 17 disease proposals (including HSS requests) in 14 countries North Africa & the Middle East - US$ 87.3** million for 5 disease proposals (including HSS requests) in 5 countries South West Asia - US$ 233.8** million for 8 disease proposals (including HSS requests) in 6 countries Sub-Saharan Africa: East Africa - US$ 709.4** million for 11 disease proposals (including HSS requests) in 9 countries Sub-Saharan Africa: Southern Africa - US$ 258.9** million for 7 disease proposals in 6 countries Sub-Saharan Africa: West & Central Africa - US$ 592.1** million for 18 disease proposals (including HSS requests) in 12 countries
By Disease	HIV US$ 1,198** million in 36 countries Tuberculosis US$ 666.6** million in 35 countries Malaria US$ 783.1** million in 19 countries
Documentation	TRP Report (PDF - 746 KB) Proposals Not Approved Board Decision Point on Round 9 and NSA (GF/B20/DP11): download (PDF - 205 KB)
	* USD exchange rate November 2009. ** Please note that amounts per region and disease do not include a 10% downward adjustment for efficiency anticipated to be achieved during TRP clarifications and grant negotiations.

Round 8 - November 2008
Total	110 programs in 68 countries approved in principle 8 November 2008 . It is noted that the Round 8 proposals are collectively intended to be subject to a 10% adjustment downwards for efficiency, resulting in an adjusted maximum Phase 1 upper ceiling funding of US$2.753 billion.
By Region	East Asia & the Pacific - US$ 387.4* million for 17 programs in 9 countries Eastern Europe & Central Asia - US$ 141.9* million for 16 programs in 9 countries Latin America & the Caribbean - US$ 161.9* million for 11 programs in 10 countries North Africa & the Middle East - US$ 147.4* million for 10 programs in 7 countries South Asia - US $ 98.3* million for 8 programs in 5 countries Sub-Saharan Africa: East Africa - US$ 796.1* million for 15 programs in 10 countries Sub-Saharan Africa: Southern Africa - US$ 414.0* million for 13 programs in 5 countries Sub-Saharan Africa: West & Central Africa - US$ 912.3* million for 20 programs in 13 countries
By Disease	HIVUS$ 1,164* million for programs in 37 countries Malaria US$ 1,568* million programs in 28 countries Tuberculosis US$ 327* million for programs in 29 countries
Documentation	TRP Report (PDF - 440 KB) Proposals Not Approved
	* Please note that amounts per region and disease do not include a 10% downward adjustment for efficiency anticipated to be achieved during TRP clarifications and grant negotiations.

Round 7 - November 2007
Total	Total approved US$ 1,119 million 73 programs in 66 countries/economies*
By Region	East Asia & the Pacific - US$ 92 million for 11 programs in 19 countries/ economies* Eastern Europe & Central Asia - US$ 38 million for 5 programs in 5 countries/ economies Latin America & the Caribbean - US$ 54 million for 10 programs in 11 countries/ economies* North Africa & the Middle East - US$ 164 million for 10 programs in 7 countries/ economies South Asia - US $97 million for 9 programs in 6 countries/economies Sub-Saharan Africa: East Africa - US$ 385 million for 9 programs in 8 countries/ economies Sub-Saharan Africa: Southern Africa - US$ 154 million for 8 programs in 6 countries/economies Sub-Saharan Africa: West & Central Africa - US$ 134 million for 11 programs in 8 countries/economies
By Disease	HIV US$ 537 million for 26 programs in 39 countries/economies* Malaria US$ 471 million for 28 programs in 27 countries/economies Tuberculosis US$ 111 million for 19 programs in 30 countries/economies*
Documentation	TRP Report (PDF - 432 KB) Proposals Not Approved
	*Including countries/economies targeted in the multi – country proposal

Round 6 - November 2006
Total	Total approved US$ 846 million in 63 countries
By Region	East Asia & the Pacific - US$ 107 million in 8 countries Eastern Europe & Central Asia - US$ 119 million in 12 country Latin America & the Caribbean - US$ 47 million in 4 countries North Africa & the Middle East - US$ 70 million in 9 countries South Asia - US$ 129 million in 5 countries Sub-Saharan Africa: East Africa - US$ 94 million in 7 countries Sub-Saharan Africa: Southern Africa - US$ 117 million in 4 countries Sub-Saharan Africa: West & Central Africa - US$ 159 million in 14 countries
By Disease	HIV US$ 453 million in 34 countries Malaria US$ 202 million in 19 countries Tuberculosis US$ 190 million in 34 countries
Documentation	TRP Report (PDF - 422 KB) List of Successful Appeals

Round 5 - September 2005
Total	Total approved US$ 770 million in 60 countries
By Region	East Asia & the Pacific - US$ 128 million in 17 countries Eastern Europe & Central Asia - US$ 27 million in 8 country Latin America & the Caribbean - US$ 54 million in 4 countries North Africa & the Middle East - US$ 63 million in 4 countries South Asia - US$ 24 million in 2 countries Sub-Saharan Africa: East Africa - US$ 135 million in 5 countries Sub-Saharan Africa: Southern Africa - US$ 124 million in 8 countries Sub-Saharan Africa: West & Central Africa - US$ 210 million in 12 countries
By Disease	HIV US$ 315 million in 25 countries HSS US$ 38 million in 3 countries Malaria US$ 202 million in 26 countries Tuberculosis US$ 213 million in 23 countries
Documentation	TRP Report (PDF - 392 KB) List of Successful Appeals

Round 4 - June 2004
Total	Total approved US$ 1,039 million in 52 countries
By Region	Africa - US$ 663 million for 34 programs in 23 countries Asia, Middle East & North Africa - US$237 million for 23 programs in 16 countries Latin America, Caribbean & Eastern Europe - US$ 139 million for 15 programs in 13 countries
By Disease	HIV US$ 469 m in 27 countries Malaria US$ 417 m in 23 countries Tuberculosis US$ 153 m in 21 countries
Documentation	TRP Report (PDF - 479 KB) List of Successful Appeals

Round 3 - November 2003
Total	US$ 623m for 71 programs in 61 countries
By Region	Africa - US$ 365m for 34 programs in 23 countries Asia, Middle East & North Africa - US$ 127m for 15 programs in 13 countries Latin America, Caribbean & Eastern Europe - US$ 130m for 22 programs in 25 countries
By Disease	HIV US$ 362m for 31 programs in 52 countries HIV/TB US$ 27m for 2 programs in 2 countries Malaria US$ 166m for 20 programs in 20 countries Tuberculosis US$ 68m for 18 programs in 18 countries
Documentation	TRP Report (PDF - 337 KB) List of Successful Appeals

Round 2 - January 2003
Total	US$ 866 million for 98 programs in 73 countries
By Region	Africa - US$ 550m for 49 programs in 30 countries Asia, Middle East & North Africa - US$ 145m for 27 programs in 27 countries Latin America, Caribbean & Eastern Europe - US$ 171m for 22 programs in 16 countries
By Disease	HIV US$ 487m for 43 programs in 52 countries HIV/TB US$ 8m for 1 program in 1 country Integrated US$ 3m for 1 program in 1 country Malaria US$ 242m for 28 programs in 37 countries Tuberculosis US$ 126m for 25 programs in 35 countries
Documentation	TRP Report (PDF - 194 KB) List of Successful Appeals

Round 1 - April 2002
Total	US$ 565 million for 55 programs in 36 countries
By Region	Africa - US$ 308m for 27 programs in 16 countries Asia, Middle East & North Africa - US$ 151m for 18 programs in 11 countries Latin America, Caribbean & Eastern Europe - US$ 106m for 10 programs in 9 countries
By Disease	HIV US$ 326m for 26 programs in 22 countries HIV/TB US$ 55m for 4 programs in 3 countries Integrated US$ 20m for 1 program in 1 country Malaria US$ 68m for 12 programs in 12 countries Tuberculosis US$ 96m for 12 programs in 12 countries
Documentation	TRP Report (N/A) List of Successful Appeals

Summary of RCC Final Resubmission Wave Funding Decisions August 2010
Total	US$ 6,952,123
By Country	Sao Tome e Principe (Malaria) - US$ 6,952,123
Documentation	TRP Report (PDF - 172 KB) Proposals Not Approved

Summary of RCC Wave 8 Funding Decisions March 2010
Total	US$ 305,938,252 in five countries
By Country	Guyana - US$ 3,217,761 Guatemala - US$ 100,966,712 Lao PDR - US$ 11,642,882 South Africa - US$ 143,086,769 Uzbekistan - US$ 47,024,128
By Disease	HIV and AIDS - US$ 290,719,768 Malaria - US$ US$ 15,218,484
Documentation	TRP Report (PDF - 87 KB) Proposals Not Approved

Summary of RCC Wave 7 Funding Decisions November 2009
Total	US$ 1,125,636,284 in seven countries
By Country	China - US$ 404,818,780 India - US$ 390,464,765 Mongolia - US$ 8,540,561 Namibia - US$ 230,943,957 Tanzania - US$ 56,466,4747 The Gambia - US$ 26,450,793 Georgia - EUR 5,374,845
By Disease	HIV and AIDS* - US$ 658,734,300 Tuberculosis - US$ 423,087,271 Malaria - US$ 43,814,713
Documentation	TRP Report (PDF - 240 KB) Proposals Not Approved

*Including HSS cross-cutting interventions

Summary of RCC Wave 6 Funding Decisions May 2009
Total	US $552,040,988 in nine countries
By Country	Bangladesh - US$ 81,312,404 Belarus - US$ 14,340,567 Guyana - US$ 47,035,818 India - US$ 302,056,162 Nepal - US$ 31,950,775 Rwanda - US$ 13,700,861 Paraguay - US$ 5,481,613 Russia - EUR 9,288,623 Georgia - EUR 33,338,933
By Disease	HIV and AIDS - US$ 488,669,764 Tuberculosis - US$ 31,420,449 Malaria - US$ 31,950,775
Documentation	TRP Report (PDF - 164 KB) Proposals Not Approved

Summary of RCC Wave 5 Funding Decisions February 2009
Total	US$ 229,193,583 in six countries
By Country	Armenia - US$ 11,906,034 Benin - US$ 60,422,029 China - US$ 205,031,814 Dominican Republic - US$ 6,405,790 Madagascar - US$ 33,798,784 Tajikistan - US$ 4,382,023
By Disease	HIV and AIDS - US$ 216,937,848 Tuberculosis - US$ 10,787,813 Malaria - US$ 94,220,813
Documentation	TRP Report (PDF - 183 KB) Proposals Not Approved

Summary of RCC Wave 4 Funding Decisions October 2008
Total	US $229,193,583 in five countries
By Country	Dominican Republic - US $45,770,388 El Salvador - US$ 14,398,031 Ghana - US$ 89,764,243 India - US$ 72,095,018 Nicaragua - US$ 7,165,903
By Disease	HIV and AIDS - US $60,168,419 Tuberculosis - US$ 79,260,921 Malaria - US$ 89,764,243
Documentation	TRP Report (PDF - 76 KB) Proposals Not Approved

Summary of RCC Wave 3 Funding Decisions July 2008
Total	US$ 513,349,804 in eight countries
By Country	Bulgaria - US $28,021,697 Cambodia - US$ 19,540,113 China - US$ 42,840,814 Cuba - US$ 9,772,998 Ethiopia - US$ 342,574,327 Haiti - US$ 46,136,317 Honduras - US$ 3,453,657 MCWP - US$ 21,009,881
By Disease	HIV and AIDS - US $426,505,339 Tuberculosis - US$ 42,840,814 Malaria - US$ 44,003,651
Documentation	TRP Report (PDF - 139 KB) Proposals Not Approved

Summary of RCC Wave 2 Funding Decisions April 2008
Total	US $364,489,068 in five countries
By Country	Malawi - US$ 173,329,414 Mongolia - US$ 3,481,740 RMCC - US$ 14,384,472 Thailand - US$ 56,157,021 Philippines - US$ 117,136,422
By Disease	HIV and AIDS - US$ 232,968,175 Tuberculosis - US$ 78,037,991 Malaria - US$ 53,482,903
Documentation	TRP Report (PDF - 177 KB) Proposals Not Approved

Summary of RCC Wave 1 Funding Decisions November 2007
Total	US$ 129,713,262 in five countries
By Country	Burundi - US$19,694,151 Honduras - US$ 25,121,194 Mongolia - US$ 3,553,729 Rwanda - US$ 21,346,817 Tanzania - US$ 59,997,371
By Disease	HIV and AIDS - US$ 47,187,023 Tuberculosis - US$ 8,454,963 Malaria - US$ 151,443,365
Documentation	TRP Report (PDF - 193 KB)

AMFm Phase 1 - November 2009
Total	10 applications to AMFm Phase 1 were approved on 11 November 2009. The total budget for supporting interventions across these applications was US$126.7 million. Of this, US$ 17.6 was requested in new funding from the Global Fund. The majority of funding for supporting interventions will be provided through reprogramming savings gained in participating countries' existing Global Fund malaria grants through the lower cost of artemisinin-based combination therapies (ACTs) under AMFm.
By Region	East Asia & the Pacific - 1 application approved with a total budget for supporting interventions of US$11 million (US$9.6 requested in new funding from the Global Fund) North Africa & Middle East - 1 application approved with a total budget for supporting interventions of US$2.1 million (US$1.7 million requested in new funding from the Global Fund) Sub-Saharan Africa: East Africa & Indian Ocean - 6 applications approved with a total budget for supporting interventions of US$47.8 million (US$6.3 million requested in new funding from the Global Fund) Sub-Saharan Africa: West & Central Africa - 2 applications approved with a total budget for supporting interventions of US$65.8 million (no new funding requested from the Global Fund)
Documentation	TRP Report (PDF - 94 KB) Applications Not Approved